Cargando…
Human Gray and White Matter Metabolomics to Differentiate APOE and Stage Dependent Changes in Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common form of dementia with hallmarks of β-amyloid (Aβ) plaques, tau tangles, and neurodegeneration. Studies have shown that neurodegeneration components, especially brain metabolic deficits, are more predictable for AD severity than Aβ and tau. However, detaile...
Autores principales: | Hammond, Tyler C., Xing, Xin, Yanckello, Lucy M., Stromberg, Arnold, Chang, Ya-Hsuan, Nelson, Peter T., Lin, Ai-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903196/ https://www.ncbi.nlm.nih.gov/pubmed/35265943 http://dx.doi.org/10.33696/immunology.3.123 |
Ejemplares similares
-
Inulin supplementation prior to mild traumatic brain injury mitigates gut dysbiosis, and brain vascular and white matter deficits in mice
por: Yanckello, Lucille M., et al.
Publicado: (2022) -
Functional connectivity between white matter and gray matter based on fMRI for Alzheimer's disease classification
por: Zhao, Jie, et al.
Publicado: (2019) -
Gray to white matter signal ratio as a novel biomarker of neurodegeneration in Alzheimer’s disease
por: Putcha, Deepti, et al.
Publicado: (2022) -
ApoE influences regional white-matter axonal density loss in Alzheimer's disease
por: Slattery, Catherine F., et al.
Publicado: (2017) -
APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
por: Mirza, Saira Saeed, et al.
Publicado: (2019)